Interferon-Alpha Reduces Human Hippocampal Neurogenesis and Increases Apoptosis via Activation of Distinct STAT1-Dependent Mechanisms
Author(s) -
Alessandra Borsini,
Annamaria Cattaneo,
Chiara Malpighi,
Sandrine Thuret,
Neil A. Harrison,
Patricia A. Zunszain,
Carmine M. Pariante
Publication year - 2017
Publication title -
the international journal of neuropsychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 107
eISSN - 1469-5111
pISSN - 1461-1457
DOI - 10.1093/ijnp/pyx083
Subject(s) - neurogenesis , hippocampal formation , apoptosis , neuroscience , alpha (finance) , microbiology and biotechnology , biology , psychology , genetics , developmental psychology , construct validity , psychometrics
In humans, interferon-α treatment for chronic viral hepatitis is a well-recognized clinical model for inflammation-induced depression, but the molecular mechanisms underlying these effects are not clear. Following peripheral administration in rodents, interferon-α induces signal transducer and activator of transcription-1 (STAT1) within the hippocampus and disrupts hippocampal neurogenesis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom